arrow
U

Urs Würtemberger

raya diagnostics
H指数:7
被引数:181

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial

O-(2-[18F]fluoroethyl)-L-tyrosine-PET引导与对比增强T1加权MRI引导的重复照射在复发性胶质母细胞瘤患者中的比较(GLIAA/NOA-10 ARO2013-01):一项多中心、开放标签、随机试验

2025-12-190
OAAI
Non-invasive Prediction of Meningioma Tumor Grade by Quantification of Shape-based Radiomics Features and Surface Regularity

Diebold, M.; Becker, L.; Demerath, T.; Reisert, M.; Erny, D.; Braun, A.; Hauser, T.K.; Grauvogel, J.; Hohenhaus, M.; Urbach, H.; 等. 基于形状放射组学特征量化及表面规则性的非侵入性预测脑膜瘤肿瘤分级。Clin. Neuroradiol. 2025. [Google Scholar] [CrossRef]

2025-09-011
OAAI
Microstructural differentiation of cerebral metastases, glioblastoma, meningioma, and primary CNS lymphoma using advanced diffusion imaging techniques

利用先进的扩散成像技术对脑转移瘤、胶质母细胞瘤、脑膜瘤和原发性中枢神经系统淋巴瘤进行微观结构分化

2025-01-010
OAAI
Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma

先进的扩散成像揭示了原发性中枢神经系统淋巴瘤的微观结构特征,可以与胶质母细胞瘤区分

2024-06-081
OAAI
Mesoscopic Assessment of Microstructure in Glioblastomas and Metastases by Merging Advanced Diffusion Imaging with Immunohistopathology

通过将高级扩散成像与免疫组织病理学相结合,对胶质母细胞瘤和转移瘤的微观结构进行介观评估

2023-10-262
PRE
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas
2023-09-151
OA